Biocon Limited

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
22-Oct-18 Motilal Oswal Positive Committee opinion Neutral 658 625 -5.02
24-Sep-18 Motilal Oswal Favorable regulatory outcome enhances biosimilars prospects Buy 665 625 -6.02
11-Apr-18 SPA Securities Front runner in Biosimilars to guide revenues going ahead 612
3-Dec-17 Motilal Oswal Mylan/ Biocon received Trastuzumab approval in US Neutral 447 485 8.5
27-Oct-17 Nirmal Bang Sec Slowdown In Biosimilar Business As Well As Licensing Income Sell 360 308 -14.44

Upcoming Events and Recent Updates

26-Jul-19
AGM/EGM xxxxxxxxx  
 
Download 15-Jun-19
Announcement - Announcement under Regulation 30 (LODR)-Allotment  ( updated on Jun 15 2019)
13-Jun-19
Investor/Analyst Presentation  ( updated on Jun 14 2019)

Analyst Calls / Meets


Management Interviews

15-May-19 Kiran Mazumdar ..  
26-Apr-19 Kiran Mazumdar ..  
27-Mar-19 Kiran Mazumdar ..  
08-Mar-19 Kiran Mazumdar ..  
07-Mar-19 Kiran Mazumdar ..  

Investor Presentations


Annual Reports
Source: Reportjunction.com

2017-18  
2016-17  
2015-16  
2014-15  
2013-14  

Research Showcase

22-Oct-18
Motilal Oswal -..
Download
24-Sep-18
Motilal Oswal -..
Download
11-Apr-18
SPA Securities ..
Download
03-Dec-17
Motilal Oswal -..
Download
27-Oct-17
Nirmal Bang Sec..
Download

Results

26-Apr-19 Results
25-Apr-19 Results
24-Jan-19 Results
25-Oct-18 Results
27-Jul-18 Results

AGM/EGM/Board Meetings

26-Jul-19 - AGM
04-Jun-19 - POM
24-Jan-19 - Quarterly Results
27-Jul-18 - AGM
08-Dec-17 - POM

Press Release

25-Apr-19 Press Release
24-Jan-19 Press Release
25-Oct-18 Press Release
19-Oct-18 Press Release
21-Sep-18 Press Release

 

Archived Documents

No Archieved Transcript.